"I would say that we have overcome the crisis from a healthcare point of view, and gained competencies and resilience, due to the extreme commitment of…
In Conversation
"The Portuguese NHS is a historic and prestigious service—similar to that of the UK—whereby the public financing is significant"
"The goal is to promote the necessary conditions to establish in Portugal a young, innovative and skilled labor force by bringing together research centers, universities and…
"At Mundipharma, we have a combination of the best talent on the market and excellent company culture. To add to that, the market in Portugal offers…
"A new generation of Portuguese entrepreneurs is investing in innovation and quality. They are working hard on the “Made in Portugal” concept."
"Portugal is of the few countries not investing enough into disease prevention."
"We have the most curious scientists with the best portfolios who are continually asking critical unanswered questions in their fields"
"Portugal compares fantastically with EU countries in terms of health targets, and globally at the primary care level we are an advanced country."
"The creation of the technologies evaluation system, SINATS, in 2015 is one of the most important milestones for Portugal and has developed extensively in the past…
When Indian generics company Aurobindo established itself in Portugal in 2010, the affiliate was faced with some difficult choices. As the latest company to enter the…
David Malta and Daniela Couto, Co-founders of Cell2B, discuss the company’s origins and plans to achieve market authorization, and what makes the fledgling company the partner…
CPH Pharma was the oldest running pharmaceutical company in Portugal until its acquisition by Grupo Ferrer in 2008. Since then, the company has continued to thrive…
